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Abstract
Introduction: Nanoparticles (NPs) are small entities that consist of a hydroxyapatite core, which can bind ions, proteins, and
other organic molecules from the surrounding environment. These small conglomerations can influence environmental
calcium levels and have the potential to modulate calcium homeostasis in vivo. Nanoparticles have been associated with
various calcium-mediated disease processes, such as atherosclerosis and kidney stone formation. We hypothesized that
nanoparticles could have an effect on other calcium-regulated processes, such as wound healing. In the present study, we
synthesized pH-sensitive calcium-based nanoparticles and investigated their ability to enhance cutaneous wound repair.
Methods: Different populations of nanoparticles were synthesized on collagen-coated plates under various growth
conditions. Bilateral dorsal cutaneous wounds were made on 8-week-old female Balb/c mice. Nanoparticles were then either
administered intravenously or applied topically to the wound bed. The rate of wound closure was quantified. Intravenously
injected nanoparticles were tracked using a FLAG detection system. The effect of nanoparticles on fibroblast contraction
and proliferation was assessed.
Results: A population of pH-sensitive calcium-based nanoparticles was identified. When intravenously administered, these
nanoparticles acutely increased the rate of wound healing. Intravenously administered nanoparticles were localized to the
wound site, as evidenced by FLAG staining. Nanoparticles increased fibroblast calcium uptake in vitro and caused
contracture of a fibroblast populated collagen lattice in a dose-dependent manner. Nanoparticles also increased the rate of
fibroblast proliferation.
Conclusion: Intravenously administered, calcium-based nanoparticles can acutely decrease open wound size via
contracture. We hypothesize that their contraction effect is mediated by the release of ionized calcium into the wound
bed, which occurs when the pH-sensitive nanoparticles disintegrate in the acidic wound microenvironment. This is the first
study to demonstrate that calcium-based nanoparticles can have a therapeutic benefit, which has important implications for
the treatment of wounds.
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Introduction
Nanoparticles were first discovered almost two decades ago and
were initially thought to be a type of ‘‘nanobacteria’’ [1,2,3,4].
However, further research determined that nanoparticles were
fundamentally different from typical living bacteria, and hence
they were renamed, ‘‘nanoparticles’’ [5,6,7,8,9]. Studies ultimately
revealed that nanoparticles were simply aberrant crystallizations of
protein and minerals [6,10,11]. Recently, Young et al. proposed
that nanoparticles can modulate environmental calcium levels and
may play a role in calcium homeostasis [6,7]. This ability to
regulate calcium homeostasis is believed to have important
physiologic and pathologic implications. Nanoparticles have
been associated with many calcium-mediated disease processes,
including cancer, kidney stone formation, and atherosclerosis
[12,13,14,15,16,17,18].
Nanoparticles can be derived from many different source
materials, but they are generally grown in the presence of serum
and have a pleomorphic shape that ranges in size from 20–
500 nm [3,6]. The morphology, chemical composition, and
physical properties of nanoparticles can be modulated by altering
the protein and ionic composition of the culture medium
[3,4,6,10,19]. Due to this intrinsic variability, it has been
proposed that nanoparticles may represent a group comprising
multiple distinct entities, each with unique characteristics [6].
However, one characteristic that is believed to be shared by
nanoparticles is their ability to modulate calcium homeo-
stasis [7].
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cutaneous injury, a cascade of events occurs which ultimately
results in tissue repair. Tissue repair is classically divided into
an inflammatory phase, a granulation phase, and a scar-
remodeling phase. A plethora of cells, enzymes, cytokines,
hormones and ions are involved in this process. One of the
most important ions involved in this process is calcium. Calcium
is a key secondary messenger that is involved in several
signaling cascades critical to wound healing [20]. Calcium influx
into cells is known to regulate inflammatory cell infiltration,
fibroblast proliferation and keratinocyte migration [21,22].
Furthermore, calcium has an established role in the normal
homeostasis of skin and is a modulator of keratinocyte prolifer-
ation and differentiation [20]. These features are highly relevant in
the skin, which exists in a perpetual state of dynamic equilibrium
with its environment.
Clinically, the direct topical application of calcium to chronic
human wounds through calcium alginate dressings has been
shown to be beneficial [23]. Multiple studies have shown that
calcium alginate dressings increase the rate wound healing [24,25].
The effect of calcium alginate dressings on cell proliferation is
mediated by the release of ionized calcium into the wound bed.
Increasing the ionized calcium concentration in the wound bed
thus promotes improved healing [20,26]. However, the greatest
improvements occur in chronic wounds, such as venous ulcers
[24]. This result suggests that topical calcium alginate is not an
ideal calcium delivery system, as it does not effectively enhance
acute wound healing.
We therefore wanted to address whether ionized calcium
could be more effectively delivered to the acute wound bed.
To do this, we engineered calcium-based nanoparticles (CNPs)
that would readily disintegrate when exposed to an acidic pH. The
pH of the acute wound microenvironment is known to be acidic,
and ranges from a pH of 5–6 [27]. Since it is also known that
calcium-phosphate minerals disintegrate in acidic conditions [28],
we hypothesized that calcium-based nanoparticles could be
designed to selectively disintegrate in the acidic wound microen-
vironment, and thereby cause a local release of ionized calcium
which would enhance the repair process. To test this hypothesis,
we designed in vitro and in vivo experiments to examine how our
pH-sensitive calcium-based nanoparticles influence the repair
process.
Materials and Methods
Ethics Statement
All animal procedures were conducted in accordance with
NIH guidelines and with approval from Stanford University’s
Administrative Panel on Laboratory Animal Care (APLAC),
protocol number 11048. APLAC guidelines for endpoint
monitoring and humane termination were strictly followed. All
animals used in this study were humanely euthanized with carbon
dioxide prior to becoming moribund. Humane endpoints were
used to reduce the duration and severity of pain and distress in
experimental animals.
Synthesis of nanoparticles
Nanoparticles were grown in 100 mm tissue culture dishes
(#353803, BD Biosciences, Franklin Lakes, NJ) that were pre-
coated with various different experimental coating solutions. The
experimental plate-coating solutions were prepared by dissolving
rat tail collagen (#11179179001, Roche, Indianapolis, IN) in
sterile 0.2% acetic acid (pH 3.0) to obtain a final collagen
concentration of 0.5 mg/ml. The ionic composition of the coating
solution was then modified by systematically varying the
concentration of CaCl2 and beta-glycerol-phosphate. In such a
fashion, multiple different coating solutions were used for making
different populations of nanoparticles. Then, 2.5 mls of coating
solution was added to a 100 mm tissue culture dish. After a few
moments, the coating solution was carefully decanted off, such that
only a thin film of coating solution remained on the bottom of the
dish. The dish was then dried and sterilized by leaving it
uncovered in a fume hood under UV light for 12–16 hours. Each
dish was washed once with PBS before growth media was added.
The growth media consisted of alpha-MEM (#12571, GIBCO/
Invitrogen, Carlsbad, California) supplemented with 20% FBS,
penicillin/streptomycin (#15070-063, GIBCO/Invitrogen), and
gentamicin (#15710-064, GIBCO/Invitrogen)]. Prior to culture,
the growth media was oxidized by aeration and sterilized by
passage through a 0.22 mm membrane five times. The nanopar-
ticles were grown in an incubator at 37uC and 5% CO2. The
media was changed every three days. Photos of nanoparticle
cultures were taken daily with a digital camera (R8, RICHO,
Tokyo, Japan) through a light microscope (CK40, Olympus,
Tokyo, Japan).
Determining the pH sensitivity of nanoparticles
Nanoparticles were synthesized in a 30 mm culture dish as
described above and were considered ready for experimentation
once the culture dish had reached near confluence. The culture
dish was first washed with MilliQ water (Millipore, Billerica, MA)
three times. Acidic solutions, ranging from pH 2.0 to pH 6.5, were
prepared by adding HCl to MilliQ water. Then, the 30 mm
culture dish containing the nanoparticles was fully submerged in a
larger 150 mm culture dish that contained 200 ml of the
appropriate acidic solution. Time lapse photographs of the
nanoparticle cultures were taken using a digital camera (R8,
RICHO, Tokyo, Japan) through a light microscope (CK40,
Olympus, Tokyo, Japan). At each pH, the rate of nanoparticle
disintegration was determined by measuring the time required for
complete nanoparticle dissolution.
Preparing nanoparticles for in vivo experiments
The nanoparticles were considered ready for in vivo experi-
mentation once the culture dish had reached near confluence,
which occurred approximately 2–4 weeks after their culture was
initiated. The culture dish was first washed with PBS three times,
500 ml PBS was added, and the dish was scraped thoroughly.
The nanoparticle solution was then centrifuged at 16,000 g for
30 min at 4uC and the resultant nanoparticle pellet was
resuspended in 500 ml of normal saline (0.90% w/v of NaCl at
900 mOsm/L).
Standardization of nanoparticle dose by electrical
conductance
To determine the relative concentration of different nanopar-
ticle preparations, an electrical conductance method was devel-
oped. A 100 ml aliquot of the CNP preparation was added to 1 ml
of MilliQ water (pH 7.0) and the conductance was measured
in mS/cm with a conductance meter (B-173, Horiba,Kyoto, Japan)
at 25uC. The concentrations of different nanoparticle preparations
were normalized based on the measured electrical conductance.
The method was validated by measuring the electrical conduc-
tance of each nanoparticle preparation at different dilution factors
to generate standard curves. The average nanoparticle prepara-
tion (resulting from one confluent 100 mm tissue culture dish) had
an electrical conductance of approximately 13 mS/cm.
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Microscopy (SEM) and Energy-Dispersive X-ray
Spectroscopy (EDX)
The nanoparticles were prepared in 100 mm dish for SEM/
EDX after 2–4 weeks of incubation. The culture dish was washed
with PBS three times. Pure water (500 ml) was added and the dish
was scraped thoroughly. An aliquot of the solution was deposited
on a glass cover slide and dried in a fume hood overnight. The
specimen was coated with gold. The nanoparticles were imaged
with a scanning electron microscope (XL30 Sirion, FEI, Hillsboro,
Oregon) and EDX was performed with the associated software
(EDAX, Ametek, NJ).
Open mouse wound model
8 week old female Balb/c mice were purchased from Charles
Rivers Laboratories (Wilmington, MA). For cutaneous injuries, the
mice were first anesthetized with isoflurane. The dorsum of each
mouse was shaved and depilated. The skin was sterilized with
betadine and 70% EtOH. All limbs were extended evenly so that
the skin on the back became relaxed and symmetric. In order to
make wound sizes as consistent as possible, the excision line was
first traced with a 6 mm punch biopsy. The skin, including the
panniculus carnosus, was carefully excised just above the
myofascial layer with scissors. The wounds were washed with
sterile saline and dressed with an anti-adhesive Telfa sheet
(#7662, Covidien, Mansfield, MA) and Tegaderm (#1626, 3M,
Maplewood, MN).
Intravenous injection of nanoparticles
Immediately after the wounds were created, mice were injected
via the tail vein with either 1) 100 mof the nanoparticle solution or
2) 100 ml of normal saline. Each experimental group consisted of
25 mice. Wound size was measured daily. Wound dressings were
removed carefully with saline, so as not to change the wound size
or shape. All limbs were extended evenly so that the skin on the
back became relaxed and symmetric. A standard silicon ring was
used as a reference frame for each photograph. Wound
photographs were taken with a digital camera (D40, Nikon,
Tokyo, Japan). The wound and reference ring areas were
measured with Image J software (public software, NIH). The ratio
of the wound area to the reference ring area was calculated, and
the rate of wound closure was determined. Wounds were stained
with picrosirius (#43665, Sigma-Aldrich, St. Louis, MO) red at
day 7 and day 12 to assess the amount collagen deposition.
Wounds were also stained using the von Kossa technique to
identify calcium deposition.
Intravenous injection of calcium chloride
Immediately after the wounds were created, mice were injected
via the tail vein with either 1) 100 ml of calcium chloride (0.6 mg/
mouse), 2) 100 ml of the nanoparticle solution, or 3) 100 mlo f
normal saline. Wound size was measured on days 0, 1, 2, 4, and
6. Wound closure rate was determined as described above for the
nanoparticle injection experiments. Wound dressings were
removed carefully with saline, so as not to change the wound
size or shape. All limbs were extended evenly so that the skin on
the back became relaxed and symmetric. A standard silicon ring
was used as a reference frame for each photograph. Wound
photographs were taken with a digital camera (D40, Nikon,
Tokyo, Japan). The wound and reference ring areas were
measured with Image J software. The ratio of the wound area
to the reference ring area was calculated and the rate of wound
closure was determined.
Serum calcium level after intravenous injection of
calcium-based nanoparticles and calcium chloride
Serum calcium levels were measured at 1 hr, 3 hr, 12 hr, 24 hr,
72 hr and 12 days after injection of either 1) 100 ml of the calcium-
based nanoparticle solution, 2) 100 ml of calcium chloride
(0.6 mg/mouse), or 3) 100 ml of normal saline. Mice were
sacrificed and blood was collected from the aorta with a
heparinized syringe (26 G needle). The blood was transferred to
a 1.5 ml tube (on ice) and centrifuged at 2000 rpm for 10 min at
4uC. The upper serum layer was transferred to another tube (on
ice). The serum calcium level was measured with a calcium assay
kit (#Z5030014, BioChain, Hayward, CA), as per the manufac-
turer’s instructions.
Tracking intravenously injected calcium-based
nanoparticles
In order to track CNPs after intravenous injection, FLAG (+)
CNPs were synthesized. To synthesize FLAG (+) CNPs, FLAG
peptide (F3290, Sigma-Aldrich, St. Louis, MO) was added to the
nanoparticle growth medium (alpha-MEM, 20% FBS, Pen/Strep/
Gent) to obtain a final FLAG peptide concentration of 100 mg/
ml. The FLAG (+) CNPs were grown in 6 well plates that had been
pre-treated with coating solution. A total of 2 ml of FLAG (+)
medium was added to each well, and the medium was changed
every three days. The FLAG (+) CNPs were considered ready for
in vivo experimentation once the culture dish had reached near
confluence, which occurred approximately 2 weeks after their
culture was initiated. The culture dish was washed with PBS three
times and scraped thoroughly. The FLAG (+) CNPs were
centrifuged at 16,000 g for 30 min at 4uC, and then resuspended
in normal saline. 100 ml of FLAG (+) CNPs were then injected via
the tail vein into wounded 8 week old female Balb/c mice. Control
mice were injected with either 100 ml of FLAG (-) CNPs or 100 ml
of normal saline. Mice were sacrificed at 0 hours, 3 hours,
24 hours, 72 hours, 7 days, and 10 days. Wound tissue was
harvested and soaked in 10% formaldehyde at 4uC overnight and
embedded in paraffin. The tissue samples were cut to a thickness
of 4 mm.
FLAG (+) CNPs were detected using a mouse monoclonal biotin-
conjugated anti-FLAG antibody (F9291, Sigma-Aldrich, St. Louis,
MO). After deparaffinization, the specimens were treated with
blocking solution (PBS with 2% horse serum and 0.1% Tween 20)
for one hour at room temperature. Antibody was diluted 1:100 with
the blocking solution, and specimens incubated with biotinylated
antibody solution overnight at 4uC. Then, specimens were washed
withthe blockingbufferthreetimes,and incubatedwiththe ABCkit
(#PK4000, Vector Laboratories, Burlingame, CA) for 30 min at
room temperature. The specimens were washed again three times
and incubated with DAB solution (#25985-50, Nacalai Tesque,
Kyoto, Japan) for exactly 4 min. The specimens were then rinsed
thoroughly with water and imaged.
Topical application of calcium-based nanoparticles
Open mouse wounds were created on 8 week old female Balb/c
mice, as described previously. The wounds were treated with a
topical application of either 1) 100 ml of the calcium-based
nanoparticle solution 2) 100 ml of calcium chloride (0.6 mg/
mouse) or 3) 100 ml of normal saline. The calcium-based
nanoparticles were applied directly to the wound bed. Calcium
chloride and normal saline controls were applied in the same
manner. Wound size was measured at 0, 1, 2, 4, 6 and 8 days. A
standard silicon ring was used as a reference frame for each
photograph. Wound photographs were taken with a digital camera
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were measured with Image J software. The ratio of the wound area
to the reference ring area was calculated.
Assessing fibroblast proliferation after treatment with
calcium-based nanoparticles
NIH3T3 cells were purchased from American Type Culture
Collection (ATCC), Manassas, VA (CRL-1658). The cells were
cultured in DMEM high glucose medium (#11995, GIBCO/
Invitrogen, Carlsbad, CA) supplemented with 10% FBS and
Penicillin/Streptomycin and grown at 37uCi n5 %C O 2. The cells
were passaged with trypsin/EDTA (#25300, GIBCO/Invitrogen,)
prior to confluence. The cells were seeded in 96 well plates
(CLS3596, Costar/Sigma-Aldrich, St. Louis, MO) at concentra-
tionsof5,000/well(50 ml/well).Afterincubation for2 days,the cells
were treated with CNPs. Calcium-based nanoparticles were pre-
pared as described above and a pellet of CNPs from a 100 mm dish
was suspended in 500 ml of medium (DMEM high glucose, 10%
FBS, Pen/Step). CNPs were then suspended in medium at dilutions
of 1:1 to 1:100. 50 ml of the CNP solution was added to each well.
Thetreatedandcontrolled wellswereincubatedfor24 hours.BrdU
labeling was then performed to quantitate proliferation
(#11647229001- BrdU (colorimetric) Cell Proliferation ELISA,
Roche, Indianapolis, IN). After addition of BrdU, plates were
incubated at 5% CO2 and 37uC for 2 hours. The 370 nm
absorbance was measured as per the manufacturer’s instructions.
Treatment of Fibroblast Populated Collagen Lattice
(FPCL) with calcium-based nanoparticles
NIH3T3 cells were cultured as described above. Trypsinized
cells were mixed with 1 mg/ml of rat tail collagen dissolved in 3
mM HCl at a concentration of 50,000 cells/ml. 500 ml of the cell-
collagen mixture was added to each well of a 24-well plate
(#353847, BD, Franklin Lakes, NJ). The FPCL gel formed at 5%
CO2 and 37uC for 2 hr. Then, 500 ml of the CNP solution
(DMEM high glucose with 10% FBS and P/S at pH 7) was added
to each well. The CNP-containing medium was replaced daily.
The 24 well plate was scanned digitally (Scanjets 5370C and
c7671b, Hewlett-Packard, Palo Alto, CA) and the size of the FPCL
was measured daily and calculated with Image J software (NIH),
normalizing to the day 0 value.
Calcium uptake in fibroblasts after treatment with
calcium-based nanoparticles
NIH3T3 cells were cultured as described above. The cells were
seeded in poly-D-lysine coated 96 well plates (#354461, BD,
Franklin Lakes, NJ) at a concentration of 5,000 cells/well (50 ml/
well). After incubation for 2 days, the cells were treated with
calcium-based nanoparticles from 1:1 to 1:100 dilution. The
medium was replaced with 50 ml/well of medium (DMEM high
glucose, 10% FBS, Pen/Step) and 50 ml of Fluo4 reagent (F10471,
Fluo-4 Direct
TM Calcium Assay Kit, Invitrogen, Carlsbad, CA).
The Fluo-4 reagent was used according to the manufacturer’s
protocol. The cells were incubated at 5% CO2 and 37uC for
30 min and subsequently incubated at room temperature for 30
min in the dark. The level of fluorescence in each well was
measured with a Cytofluor 2 plate-reader (PerSeptive Biosystems,
Framingham, MA). The excitation and emission wavelengths were
492/20 and 528/30, respectively.
Statistical Analysis
Data involving only two groups was analyzed with an
independent sample two tailed t-test assuming unequal variances.
When more than two experimental groups were compared, the
data was analyzed using Dunnett’s multicomparison test to
compare data between individual experimental groups and the
corresponding control. A p-value value of , 0.05 was considered
to be statistically significant for all tests. All data presented
graphically in figures is expressed as the mean 6 SD.
Results
Nanoparticle formation
Nanoparticles formed on plate surfaces and were first visible as
tiny circular-shaped particles at day 3 (Figure 1A). The particles
grew in both size and number, and were pleomorphic. The
particles were firmly attached to the collagenous coating solution
on the dish surface. To confirm that the particles were not bacteria
(or any type of living organism), the particles were cultured in 6%
sodium hypochlorite overnight with UV radiation. The particles
were stable in bleach and UV radiation (data not shown). Figure 1
(B and C) demonstrates that the size of the individual
nanoparticles ranged between 50-200 nm in vitro. Over time, the
individual small circular precipitates grew in size and became
confluent on day 14.
Disintegration of calcium-based nanoparticles occurs in a
pH-dependent fashion
To assess the effect of environmental pH on the stability of
calcium-based nanoparticles, near-confluent cultures of CNPs
were treated with acid (HCl titrated to pH of 2.0–6.5). A relatively
large volume of acid (200 ml) was used to treat the CNPs, in order
to mitigate the pH buffering effect of the nanoparticles.
Interestingly, the CNPs buffered the pH of the solution and
maintained an equilibrium pH of 7.4 when 8 mL of acid solution
was added to a near-confluent 100 mm dish of nanoparticles.
However, the buffering capacity of CNPs was exceeded when
200 ml of acid was added. The rate of CNP disintegration was
directly related to the pH of the environment. At a pH of 2.0, the
CNPs completely disintegrated within 2 min. As the pH was
increased, the rate of CNP disintegration decreased until a pH 5.5.
No appreciable CNP disintegration occurred after 48 hours of
incubation in pH 6.0 solution.
Therapeutic effect of nanoparticles depends on culture
conditions
The physical properties and therapeutic effect of nanoparticles
were found to vary based on the ionic composition of the coating
solution used. The size, shape, growth characteristics, and
therapeutic effect of nanoparticles could be modulated by altering
the concentrations of CaCl2 and beta-glycerol-phosphate in the
coating solution. Figure 2 demonstrates how the rate of wound
closure was affected by the ionic composition of the coating
solution used to synthesize the nanoparticles. The nanoparticle
population with the greatest effect on wound healing was
synthesized using a coating solution that contained CaCl2 and
beta-glycerol-phosphate at concentrations of 2 mM and 5 mM
respectively. All subsequent experiments were performed using
calcium-based nanoparticles that had been synthesized using the
aforementioned coating solution.
Ionic composition of calcium-based nanoparticles
Scanning electron microscopy (SEM) of the CNPs showed that
their sized ranged from 50-200 nm. Energy dispersive x-ray (EDX)
spectral analysis of these particles showed a high peak of calcium
(Figure 3). The spectrum is also suggestive of the presence of
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oxygen. This data is consistent with the spectral analysis of other
previously reported nanoparticles [6,7].
Intravenous injection of calcium-based nanoparticles
accelerates wound healing and decreases scar formation
in excisional mouse wounds
The effect of calcium-based nanoparticles on wound healing
was investigated on open 8 mm full thickness excisional mouse skin
wounds. Mice received a single injection of calcium-based
nanoparticles at the time of injury. For the first 24 hours following
injury, the rate of wound closure was found to be significantly
faster in calcium-based nanoparticle treated mice. However, after
24 hours, the rate of wound closure was similar between CNP-
treated and control mice (Figures 4A and 4B). Although the rate of
wound closure approximated controls after 24 hours, the absolute
wound size remained significantly smaller in CNP-treated mice at
all time points. Wounds were stained with picrosirius red to assess
the amount of collagen deposition. Sections were taken from the
center of wounds. At day 7, CNP-treated mice had wounds with
increased collagen deposition relative to controls. However, by day
12, CNP-treated mice had healed with less collagen deposition
than controls (Figure 4C).
Intravenous injection of calcium chloride accelerates
wound healing while significantly increasing serum
calcium levels
In order to determine if calcium alone would have the same
wound-healing effect as calcium-based nanoparticles, mice received
an intravenous injection of calcium chloride (0.6 mg/mouse)
immediately following cutaneous injury. The rate of wound healing
was found to be accelerated in mice receiving both calcium chloride
and calcium-based nanoparticles (Figure 5A). However, by day 2
the rate of wound healing was found to be faster in mice receiving
CNPs versus calcium chloride. Although the rate of wound healing
was enhanced in both CNP-treated and calcium-treated mice, mice
treated with intravenous calcium chloride experienced negative side
effects due to hypercalcemia. All experimental mice treated with
intravenous calcium chloride demonstrated significant muscle
tetany that lasted for approximately 1 hour following treatment.
Furthermore, approximately 20% of mice receiving intravenous
calcium chloride died within minutes of treatment due to cardiac
arrest. When the serum calcium levels were analyzed, it was found
that mice receiving calcium chloride had total serum calcium levels
that were approximately 2.5x greater than controls (Figure 5B). In
CNP-treated mice, there was no evidence of negative side effects
due to hypercalcemia. No experimental mice receiving CNPs
displayed signs of muscle tetany, and no CNP-treated mice died
following treatment. The serum calcium levels in CNP-treated mice
were found to be within normal limits and approximated that of
control mice (Figure 5B).
Topical administration of calcium-based nanoparticles
does not accelerate wound healing
In order to assess the effect of localized delivery of calcium-
based nanoparticles, groups of wounded mice received a topical
application of either CNPs, calcium chloride, or normal saline.
Wounds were measured at 0, 1, 2, 4, and 6 days. Topical
application of CNPs did not significantly change the wound
healing rate (Figure 6). However, consistent with previous studies
[20,23,24,25], the direct topical application of calcium chloride
accelerated the wound healing rate (Figure 6).
Calcium-based nanoparticles increase fibroblast
proliferation and contraction
In order to further investigate the mechanism by which
nanoparticles accelerate wound repair, we investigated their effect
Figure 1. The growth and morphology of calcium-based
nanoparticles in culture. (A) Small circular particles were visible on
the culture plates starting at day 3. The particles grew in both size and
number, and were pleomorphic. Over time, the particles began to
coalesce, and by day 14 they were confluent. Scale bar = 10 mm (B)
SEM of calcium-based nanoparticles on day 14 at 200,000x. (C) SEM of
calcium-based nanoparticles on day 14 at 80,000x.
doi:10.1371/journal.pone.0027106.g001
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poration was performed to assess their effect on proliferation.
Fibroblasts were incubated for 2 days, treated with nanoparticles
from 1:1 to 1:100 dilution, and then incubated for 24 hours.
Calcium-based nanoparticle treatment induced a ,25% increase
in BrdU incorporation at the highest CNP concentration
(Figure 7A).
Fibroblast-populated collagen lattice (FPCL) was performed
to determine the effects of CNP treatment on cellular contrac-
tion. NIH3T3 fibroblasts were cultured in a collagen lattice,
and CNPs were added daily for 5 days. While the collagen
lattice contracted with time, CNP treatment enhanced this
contraction in a dose-dependent manner compared to controls
(Figure 7B).
Calcium-based nanoparticles are a vehicle for the
delivery of calcium to the wound bed
Due to the pH-sensitivity of our calcium-based nanoparticles, we
hypothesized that CNPs accelerated wound healing by releasing
calcium into the acidic wound microenvironment. Thislocal release
of calcium would then induce fibroblast proliferation and cause
wound contracture, as we observed in our in vitro experiments. In
order to test this hypothesis, nanoparticles were synthesized with an
incorporated FLAG peptide. These FLAG (+) CNPs were then
tracked using immunohistochemical assays. Immediately following
cutaneous injury, mice received an intravenous injection of FLAG
(+) CNPs. The wound tissue was harvested, and the FLAG peptide
probed. Significantly more FLAG staining in the wound beds of
Figure 2. Therapeutic effect of nanoparticles depends on growth parameters. Four different populations of calcium-based nanoparticles
(NPs) were synthesized (represented as NP 1 through NP 4). For each population, the concentration of calcium chloride and glycerol phosphate were
varied in the coating material. NP 1: collagen (0.5 mg/ml). NP 2: collagen (0.5 mg/ml) + beta-glycerophosphate (5 mM). NP 3: collagen (0.5 mg/ml) +
CaCl2 (2 mM). NP 4: collagen (0.5 mg/ml) + beta-glycerophosphate (5 mM) + CaCl2. These different nanoparticle populations were injected through
the tail vein of wounded mice, and the rate of wound healing was assessed for each group. Each nanoparticle population had a different effect on
wound healing. P-values were calculated using the Dunnett’s test. The data is expressed as the mean 6 SD.
doi:10.1371/journal.pone.0027106.g002
Figure 3. The ionic composition of calcium-based nanoparticles. SEM/EDX analysis demonstrates the ionic composition of our calcium-based
nanoparticles. These nanoparticles represent a collection of charged ions including oxygen, sodium, silica, phosphorous, potassium, and calcium. The
predominant ions are calcium, oxygen, and phosphate. Note: Ka represents the energy yield from the L R K electronic orbital transition and Kb
represents the energy yield from the M R K electronic orbital transition.
doi:10.1371/journal.pone.0027106.g003
Nanoparticles Improve Wound Healing
PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27106Nanoparticles Improve Wound Healing
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27106mice treated with FLAG (+) CNPs, compared to mice treated with
FLAG (-) CNPs, or normal saline occurred (Figure 8A). FLAG
staining was most prominent in the deep muscle layer of the wound
bed (Figure 8A). The FLAG stain was greatest at day 1, and then
substantially decreased in intensity over subsequent days. The
FLAG-positive CNPs appeared to localize specifically to sites of
injury,astherewasnoevidenceofFLAGstaininnon-woundedskin
tissue. Furthermore, increased calcium deposition in the deep
wound bed of CNP-treated mice was demonstrated by von Kossa
stain (Figure 8B).
Figure 4. Intravenous injection of calcium-based nanoparticles accelerates healing of open mouse wounds. (A) Representative
photographs of mouse cutaneous wounds injected with calcium-based nanoparticle (CNP) suspension, or saline control. Differential healing was
observed at all five time points checked (N=5 for each time point). (B) Quantification of the wound area in nanoparticle-and control-treated wounds
from days 0-9. The data is expressed as the mean 6 SD. P-values were calculated using the Student’s t-test (two-tailed). (C) Histologic sections
representing the degree of collagen deposition in nanoparticle-treated vs. control wounds. Sections were taken from the center of wounds and
stained with picrosirius red at post-injury days 7 and 12. Collagen deposition was qualitatively more rapid in nanoparticle-treated wounds.
doi:10.1371/journal.pone.0027106.g004
Figure 5. Intravenous injection of calcium chloride and calcium-based nanoparticles. (A) Wounded mice received an injection of either
calcium chloride, calcium-based nanoparticles (CNPs) or saline via the tail vein. The rate of wound healing was assessed after treatment in each group.
Both calcium chloride and CNP-treatment accelerated wound healing relative to controls. CNP-treatment significantly decreased wound area
compared to calcium chloride treatment by day 2 (N=4 per group). P-values were calculated using the Dunnett’s test. The data is expressed as the
mean 6 SD. (B) Serum calcium levels of mice were measured after they received an injection of calcium chloride, calcium-based nanoparticles or
saline. Serum calcium levels remained unchanged after CNP injection, but were significantly increased 1 hour after CaCl2 injection.
doi:10.1371/journal.pone.0027106.g005
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to deliver calcium intracellularly, the fluorescence of Fluo4 AM
was measured in NIH3T3 fibroblasts before and after treatment
with nanoparticles. Fluo4 AM is a fluorescent calcium indicator
and is used to measure Ca
2+ levels inside living cells. Calcium-
based nanoparticle treatment increased calcium influx in a dose
dependent manner (Figure 9).
Discussion
The results presented here, for the first time, indicate that
nanoparticles may have a potential therapeutic benefit. Nanopar-
ticles have been associated with various calcium-mediated disease
processes, but there have been no reports suggesting that
nanoparticles can potentially influence calcium homeostasis in a
favorable manner. We reasoned that if nanoparticles can modulate
environmental calcium levels as previously suggested [6,7], then
perhaps nanoparticles could be engineered to disintegrate and
release calcium in an acidic environment. Nanoparticles could
thereby selectively increase ionized calcium levels in acidic wound
tissue. Our results demonstrate that calcium-based nanoparticles
can be designed to release calcium as a function of pH, and when
injected intravenously these calcium-based nanoparticles can
accelerate acute cutaneous wound healing by causing wound
contracture.
Nanoparticles were originally thought to be living organisms,
but more recently they have been described as a group of abiotic
entities with distinct chemical and physical properties [5]. In this
study, the nanoparticle growth parameters were modified
extensively in order to generate calcium-based nanoparticles that
could effectively enhance wound healing. We found that the size,
morphology, and growth characteristics of nanoparticles were
highly dependent on the source materials and growth parameters
used. We initially selected for nanoparticle populations that were
microscopically similar to those previously described. Then, we
selected for populations of nanoparticles that demonstrated pH
sensitivity within the range of what is expected in the acute wound
environment. Finally, we tested four different nanoparticle
populations in vivo, and found that each had variable effects on
wound healing (Figure 2). The nanoparticle population that was
found to be most effective in wound healing was grown on a
substrate that contained 2 mM CaCl2 and 5 mM beta-glycerol-
phosphate. Our data demonstrates that the physiologic properties
of nanoparticles can be altered by modulating growth parameters
and culture conditions. Therefore, enhancement of the beneficial
wound healing properties of calcium-based nanoparticles is likely
possible with further modulation of growth parameters and culture
conditions.
The acute wound microenvironment is known to be acidic and
has a pH that ranges between 5-6 [27]. This temporary and
localized acidosis is caused by an accumulation of lactic acid that
results from cellular hypoxia at the wound margin combined with
an increased metabolic oxygen demand during the healing process
[27]. Since calcium-phosphate minerals dissolve in the presence of
acidic conditions [28], we reasoned that nanoparticles could
potentially function as a pH-based calcium delivery vehicle. We
developed a population of calcium-based nanoparticles that
readily disintegrated and released their calcium payloads when
the environmental pH dropped below pH 5.5. By administering
these pH-sensitive calcium-based nanoparticles intravenously,
calcium could then be selectively deployed in acidic regions of
the body, such as wound sites. This pH-based delivery system
allowed for localized delivery of calcium, without any effect on
total serum calcium levels.
Delivery of calcium to the wound bed enhances healing
[20,23,24,25]. An influx of calcium is an essential component of
the repair process, and the addition of exogenous calcium can
enhance wound healing. Calcium exerts its therapeutic effect on
wound healing via multiple mechanisms and results in faster, more
efficient repair. In the present study,we attemptedto deliver ionized
calcium to the wound bed using calcium-based nanoparticles. We
administered these CNPs both topically and intravenously, and
compared their effect on wound healing to that of calcium chloride.
Consistent with previous studies [20,23,24,25], we found that the
topical application of calcium chloride increased the rate of wound
healing. However, the topical application of CNPs did not
Figure 6. Topical administration of calcium-based nanoparticles does not accelerate wound healing. Wounded mice received a topical
application of either calcium chloride, calcium-based nanoparticles (CNPs) or saline. Topically applied calcium-based nanoparticles did not enhance
wound healing. However, topically applied calcium chloride significantly increased the rate of wound healing relative to controls. P-values were
calculated using the Dunnett’s test. The data is expressed as the mean 6 SD.
doi:10.1371/journal.pone.0027106.g006
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readily release their calcium payloads when applied topically. This
suggests that the wound surface environment may not be conducive
towards nanoparticle calcium-release. Another potential explana-
tion for why topically applied nanoparticles did not accelerate
wound healing relates to nanoparticle internalization into cellular
compartments. Recently, internalization of nanoparticles into the
cellular lysosomal compartment has been shown in vitro [29]. If
internalization of nanoparticles into the cellular compartment is a
mechanism responsible for nanoparticle-mediated effects, then
perhaps nanoparticle internalization occurs more readily when
they are delivered intravenously. That being said, the pharmaco-
kinetics behind nanoparticle delivery deserves further investigation
in order to better understand their mechanism of action.
Although intravenous calcium chloride treatment accelerated
wound healing, significant calcium-related side-effects occurred.
Intravenous calcium chloride caused dramatic elevations in the
total serum calcium levels and this treatment was associated with
significant morbidity and mortality. However, as opposed to
treatment with intravenous calcium chloride, treatment with
intravenous calcium-based nanoparticles rapidly accelerated
wound healing but did not elevate serum calcium levels and did
not result in any morbidity/mortality. These observations
demonstrate the benefit of selectively delivering calcium to wound
sites.
No significant difference in wound healing rates between
intravenously administered calcium-based nanoparticles and
topically applied calcium chloride were observed. Given the
potential risks associated with intravenous administration of
nanoparticles, it is not clear if treatment with calcium-based
nanoparticles is superior to topically applied calcium chloride.
However, we found that the physiologic effects of calcium-based
Figure 7. Calcium-based nanoparticles increase fibroblast proliferation and contraction. (A) BrdU incorporation after 12 hrs of growth
with calcium-based nanoparticles (CNP) in NIH3T3 fibroblasts. CNP-treatment increased fibroblast proliferation rate, which was dependent on CNP
concentration in a dose-dependent manner. (B) Fibroblasts were added to a collagen lattice to form a fibroblast populated lattice complex. The
surface area of the FPCL reduced over time depending on CNP concentration. The amount of contractility is inversely proportional to FPCL size. CNP-
treatment increased FPCL contraction. P-values were calculated using the Dunnett’s test. The data is expressed as the mean 6 SD.
doi:10.1371/journal.pone.0027106.g007
Nanoparticles Improve Wound Healing
PLoS ONE | www.plosone.org 10 November 2011 | Volume 6 | Issue 11 | e27106nanoparticles can be dramatically changed by altering their growth
parameters. By continuing to optimize their growth parameters and
dosing schedule, we may be able to develop a nanoparticle-based
calcium delivery system that outperforms topical calcium chloride
and be therapeutic for acute wound healing. The present findings
demonstrate that calcium-based nanoparticles can be used as a pH-
based calcium delivery vehicle and can enhance wound healing, but
further studies are needed to determine whether this system is
superior to topical calcium chloride.
On a technical note, we developed a new method for
determining the dose of nanoparticles given to our experimental
animals. By measuring the electrical conductance of a nanoparticle
preparation, the relative concentration could be determined. For
our in vivo studies, each animal in the treatment group received 1
dose of nanoparticles. We defined a ‘‘dose’’ to be the amount of
nanoparticles derived from one confluent 100 mm tissue culture
dish. We found that the average dose was 100 ml of a nanoparticle
solution that had an electrical conductivity of 13 mS/cm. Although
Figure 8. Calcium-based nanoparticles are a vehicle for the delivery of calcium to the wound bed. (A) Intravenously injected FLAG (+)
calcium-based nanoparticles (CNPs) are detected using an anti-FLAG antibody on day 1. FLAG (+) cells are located in the epidermal, dermal, and
panniculus carnosus muscle layers at the wound site. Scale bars for 10x images = 100 mm, for 40x images = 20 mm. (B) Von Kossa staining
demonstrates calcium (black dots) in the deep wound bed of the CNP-treated mice. Scale bars for 5x images = 200 mm; for 40x images = 20 mm.
doi:10.1371/journal.pone.0027106.g008
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nanoparticles, our final results were highly consistent across
multiple different preparations of nanoparticles.
In future studies, we plan to vary the dose of calcium-based
nanoparticles given in order to develop a dose-response curve. The
rate and quality of wound repair may be further enhanced by
administering larger or more frequent doses of CNPs. In the
present study, we found that the rate of wound healing was only
increased during the first 24 hours following treatment with CNPs,
after which point the rate of wound healing paralleled that of
controls. Experiments are planned to assess whether serial
injections of CNPs can be used to maintain the increased rate of
wound healing beyond 24 hours.
Although we observed no evidence of nanoparticle-related
toxicity, this may change with higher or more frequent dosing.
Previous animal studies have shown that intravenous injections of
nanoparticles can induce an immune sensitizing response [30]. If
immune sensitization were to occur after initial exposure to
calcium-based nanoparticles, this may result in an adverse
immune reaction upon subsequent exposure. Animals in our
study received one dose of nanoparticles at the time of wounding,
and were not subjected to a second dose in which a sensitization
reaction could occur.
Furthermore, studies suggested that nanoparticles may lead to
pathologic calcification, such as atherosclerosis [31]. However, this
evidence has recently been called into question [32]. The use of c-
FBS has led to publications implicating nanoparticles in the
pathogenesis of many diseases, and most of these studies were
based on the underlying assumption that the gamma-irradiated
serum used to culture nanoparticles was sterile, and thus any
nanoparticle growth originated from the specific tissue sample under
investigation. Martel and colleagues demonstrated that this
underlying assumption is fundamentally flawed, and that non-
irradiated serum produces nanoparticles that are equivalent to those
produced using gamma-irradiated serum [32]. Therefore, the
nanoparticles that presumably were derived from the tissue sample
under investigation were actually derived from a combination of
antigens present in the c-FBS, in addition to antigens present in the
experimental tissue sample. The use of c-FBS to culture nanopar-
ticles predisposes to introducing organic components from foreign
species,which mayconfoundexperimentalfindings.Inourstudy,no
attempt was made to culture nanoparticles from experimental tissue
samples, as this would potentially lead to erroneous and misleading
results. Although we used hybrid nanoparticles in our experiments,
our results indicate that nanoparticle-based calcium delivery is
fundamentally a biochemical phenomenon that is independent of
the host animal under investigation.
In the present study, we have shown that calcium-based
nanoparticles derived from FBS can be designed to function as a
calcium delivery vehicle that disintegrates as a function of pH, and
can thus be used to selectively deliver calcium to the acidic wound
microenvironment, thereby accelerating cutaneous wound heal-
ing. Presumably, this calcium delivery system is not species specific
and the calcium-binding proteins used to form the core of our
nanoparticles can be derived from sources other than FBS. Future
studies will aim to produce species-specific nanoparticles that
consist of calcium-binding proteins that are native to the animal
species under investigation.
The present study was only designed to investigate the acute
effects of nanoparticles, and animals were sacrificed immediately
afterwoundhealing wascomplete.Futurestudieswillbedesignedto
assess the long-term effects of our calcium-based nanoparticles and
their impact on tissues outside of the wound bed. The present study
provides proof-of-concept that calcium-based nanoparticles can be
used as a vehicle to selectively deliver calcium to the acidic wound
microenvironment, and thereby enhance cutaneous wound healing.
Theoretically, this strategy could be used to selectively deliver other
ionically charged payloads to acidic microenvironments.
Although nanoparticles have been studied for over a decade,
these are the first experiments to demonstrate that nanoparticles
may have a potential therapeutic benefit. Nanoparticle delivery of
calcium directly to sites of injury is a novel concept that may be
used to effectively improve wound healing. Herein we show that
calcium-based nanoparticles can be designed such that they
release calcium as a function of pH, but more studies are needed to
further optimize this delivery system.
Author Contributions
Conceived and designed the experiments: KK BJL ALC ML HPL.
Performed the experiments: KK BJL HI SN. Analyzed the data: KK BJL
ALC ML HPL HI. Contributed reagents/materials/analysis tools: KK
BJL ALC ML HPL SN. Wrote the paper: KK BJL ALC ML HPL.
Figure 9. Calcium-based nanoparticle treatment increases fibroblast calcium uptake. Fibroblasts in culture showed increased calcium
uptake in a dose dependent manner after calcium-based nanoparticle treatment. P-values were calculated using the Dunnett’s test. The data is
expressed as the mean 6 SD.
doi:10.1371/journal.pone.0027106.g009
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